REG - Fevertree Drinks PLC - 2018 Annual Report and Notice of AGM

Fevertree DrinksAnnouncement

23/04/2019 07:05

RNS Number : 7600W
Fevertree Drinks PLC
23 April 2019
 


23rd April 2019
 
Fevertree Drinks plc
 ("Fever-Tree" or the "Company")
 
2018 Annual Report and Notice of Annual General Meeting
Fever-Tree, the world's leading supplier of premium carbonated mixers, has posted its 2018 Annual Report and Notice of 2018 Annual General Meeting to shareholders.
The 2018 Annual Report is now available to view on the Company's website at www.fever-tree.com/investors.
The Company's 2018 Annual General Meeting will be held at 11.30am on 24 May 2019 at the offices of Osborne Clarke, One London Wall, London, EC2Y 5EB.
 
Ends
 
For further information:
 



Fevertree Drinks plc                            


+44 (0)20 7349 4922




Tim Warrillow, Co-founder and CEO








Andy Branchflower, Finance Director








Oliver Winters, Communications & IR Director








     








Numis Securities - Nominated Adviser and Joint Broker 


+44 (0)20 7260 1000




Garry Levin








Matt Lewis








Hugo Rubinstein


















Investec Bank plc - Joint Broker        


+44 (0)20 7597 5970




David Flin








Alex Wright








David Anderson 


















Brunswick Group                                  


+44 (0) 20 7404 5959




Jonathan Glass








Fiona Micallef-Eynaud








Cerith Evans







 
 
Notes to Editors:
 
Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On-Trade") as well as selected retail outlets ("Off-Trade").
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGUGDSDUDBGCX